At The Uromigos Live & Unplugged event, Peter O’Donnell, MD, University of Chicago, expresses his pleasure with all of the new and impressive data to come out at ESMO in bladder cancer, including EV-302 and CheckMate 901.
Additionally, he offers a positive outlook on the future of bladder cancer in the not-so-far future.